Thursday, September 10, 2009

Drug news: Albumin & RU-10

Currently on hold but hopefully not dead.

Dry eye is targeted for development of the drug that contains gene recombination human serum albumin as an effective ingredient. Though the clinical study is currently interrupted, we intend to look for overseas affiliation soon because the need for treatment of dry eye is globally unmet (that is, there are currently few therapeutic drugs).

PRNewsire, July 31

No comments: